Exclusion of indigenous voices hinders HIV progress in Latin America

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without access to life-saving medicines and prevention tools.

Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea

Dive Brief: Vivos Therapeutics has received 510(k) clearance for the use of its oral devices in adults with severe obstructive sleep apnea (OSA). The Food

November 30, 2023

Molnupiravir May Offer Modest 6-Month Benefits for High-Risk COVID Patients

People with acute COVID-19 who took the antiviral drug molnupiravir (Lagevrio) reported modest improvements in symptoms, less time off from work or study, and less

September 12, 2024

Epic Overdose Tales: Three LSD Trips that Flip the ‘Bad Trip’ Script | Psychedelic Spotlight

Psychedelic researchers have campaigned against the “good vs bad trip” concept for years. They theorize these potent compounds are complex “non-specific amplifiers”, broadly activating neural

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.